Back

Pharma

5th Medical Devices & SaMD: AI, Regulatory and Compliance

  • 20th – 21st November 2025
  • Germany flag Germany Berlin & Online

Where Devices and Software Meet Safety: Navigating AI, Regulation & Innovation in Medech 

Join industry experts at the 5th Medical Devices & SaMD Summit on 20–21 November 2025 in Berlin. Gain practical insights into MDR, IVDR, FDA, and the upcoming AI Act. Master SaMD development from design to approval, align your QMS with IEC 62304 and ISO standards, and apply risk management across the lifecycle. Learn how to meet AI transparency rules, cybersecurity regulations, and streamline submissions with automation. Network with peers across software, compliance, and product development

Read more

About The 5th Medical Devices & SaMD: AI, Regulatory and Compliance I #EdeviceS

The 5th Medical Devices & SaMD: AI, Regulatory and Compliance Summit (#EdeviceS) to be hosted in Berlin, 20–21 November 2025, at a time when the convergence of medical technology and advanced software is redefining the regulatory landscape.

As AI-powered functionalities become integral to modern medical devices and SaMD solutions, companies face a tightening web of compliance obligations across global markets. From the EU MDR and IVDR to the FDA’s digital health regulations and the anticipated EU AI Act, manufacturers must navigate overlapping frameworks with diverging expectations—all while accelerating innovation and managing risk.

At the same time, real-world case studies have revealed critical gaps:

  • Delays in market access due to incomplete or misaligned technical documentation
  • Increased notified body scrutiny around software lifecycle evidence, particularly under IEC 62304
  • Confusion over the classification of AI-enabled software, especially borderline cases involving decision support
  • Rising concerns around cybersecurity breaches, bias in machine learning models, and post-market performance tracking

The industry is also grappling with how to integrate structured, modular regulatory submissions, adopt automation in clinical evaluation, and maintain transparency and explainability in AI outputs—all without slowing innovation pipelines.

This summit directly addresses those needs with:

  • Deep-dive presentations on regulatory expectations and updates (EU, FDA, AI Act)
  • Real-world solutions to QMS alignment, software documentation, and SaMD lifecycle management
  • Interactive sessions on AI transparency, cybersecurity, and risk/benefit evaluations
  • Cross-functional insights from regulatory, R&D, and software leaders

Whether you're building novel software-driven diagnostics, improving post-market surveillance processes, or preparing for AI-specific conformity assessments, #EdeviceS provides the actionable insight and expert dialogue to move your projects forward—with compliance and confidence.

 

Who Should Attend

Chief Executives, Directors, Vice Presidents, Department Heads, Leaders, Senior Managers, Principal Scientists and Engineers specialising in:

  • Regulatory Affairs & Regulatory Strategy
  • Quality Assurance (QA) & Quality Control (QC)
  • Software as a Medical Device (SaMD)
  • Artificial Intelligence & Machine Learning in MedTech
  • Product Development & Innovation
  • Systems & Software Engineering
  • Clinical Evaluation & Clinical Affairs
  • Compliance, Risk Management & Safety
  • Research & Development (R&D)
  • Medical Device Design & Engineering
  • Human Factors & Usability
  • Cybersecurity & Data Governance
  • Technical Documentation & Submission Strategy
  • Global Market Access & Registration
  • Health Economics & Patient Safety
  • Digital Health, Connected Devices & Data Science
  • Manufacturing, Operations & Supply Chain for Medical Devices

Register by July 31st! 

Grab Your Spot – Early Bird Round 1 Is Active

The Early Bird Offer expires in 15 days!

REQUEST A BROCHURE

To request an agenda for this Summit, please complete the details below. We will send you the agenda via email.

KEY PRACTICAL LEARNING POINTS

  • Stay up to date on global regulations: EU MDR, IVDR, FDA, and the evolving AI Act for medical technologies.
  • Understand the full lifecycle of SaMD development: from design control and software architecture to regulatory approval.
  • Learn how to align your Quality Management System (QMS) and technical documentation with AI and software-specific standards (IEC 62304, ISO 14971, ISO 13485).
  • Apply risk management principles across the development lifecycle using real-world examples and engineer-driven workflows.
  • Navigate PMCF strategies, SSCP requirements, and clinical evaluation reports to maintain compliance under MDR.
  • Understand the classification of AI-powered medical devices, how to meet transparency and bias requirements, and prepare for conformity assessments.
  • Build secure, connected devices that meet cybersecurity regulations and integrate data privacy by design.
  • Learn strategies to streamline regulatory submissions through automation, structured data, and AI-assisted clinical evaluations.
  • Address challenges with combination products, borderline classifications, and notified body feedback.
  • Exchange best practices with peers in software engineering, regulatory strategy, and product development during interactive sessions and panels.

Register by July 31st! 

Grab Your Spot – Early Bird Round 1 Is Active

The Early Bird Offer expires in 15 days!

Dr. Hans-Martin von Stockhausen

Principal Key Expert for Cybersecurity

Siemens Healthineers

Dr. Hans-Martin von Stockhausen is a Principal Key Expert for Cybersecurity at Siemens Healthineers. With over 25 years of experience in the medical device industry and a background in medical informatics, he has gained extensive domain knowledge throughout the product lifecycle. Since more than a decade, Dr. von Stockhausen has focused on product security, holding various positions such as a member of the Siemens-wide product and solution security board, business line product security officer, senior product manager, and recently starting as customer advocate.

As a member of the corporate cybersecurity governance organization, he is dedicated to improving and maintaining the security posture of products, the quality of vulnerability management processes, and security-related customer communication. Dr. von Stockhausen participates in expert workshops and talks at conferences held by European and internationally recognized organizations. He is a member of the board of directors of the Health-ISAC.

Dr. Saurabh Bhavsar, CH

Program Manager Digital Health

Ypsomed AG 

Dr. Fatima Sanfourche, DE

Global Sr. Director of QA & RA Compliance for Medical devices, Combination products, and eHealth

Bayer

Dr. Sepanta Fazaeli, NL

Clinical Systems & Medical Data Lead

Stryker

As Clinical Systems & Medical Data Lead at Stryker, Sepanta Fazaeli drives T&E and enterprise-wide AI and data transformation efforts, with a focus on system-level integration, intelligent automation, and digital readiness. He leads strategic initiatives that modernize evidence management and operationalize AI across business units, bridging clinical, regulatory, and technical domains.

With a background in clinical data sciences and deep experience in implementing AI-powered solutions in regulated environments, Sepanta specializes in building scalable, reproducible systems that enable compliant automation in high-stakes domains. His work spans AI strategy, data governance, and enterprise infrastructure, bringing a systems-thinking approach to embedding intelligence where it matters most.

He also represents Stryker on the MedTech Europe AI Act Task Force, a cross-industry working group focused on the evolving regulatory landscape for AI-enabled medical devices. In this role, he contributes to collective industry responses, helping to interpret and shape the implementation of the EU AI Act in ways that safeguard patient safety while enabling innovation. His involvement emphasizes the need for clear, practical, and risk-based approaches to AI regulation in the MedTech sector.

Alice Robertson, UK

PMCF Senior Executive

Purdie Pascoe

Alice has worked as a Senior Research Executive in the Post Market Clinical Follow Up (PMCF) team at Purdie Pascoe, specialising in PMCF surveys for medical devices, since the start of 2023. She works with manufacturers across a range of device types and risk classifications to successfully plan, design and implement both Level 4 (high quality) and Level 8 (general usability) PMCF surveys.

Chris Webb, UK

PMCF Manager

Purdie Pascoe

Chris joined Purdie Pascoe in 2019 with a BSc in Biochemistry and Molecular Medicine from the University of Nottingham. Since then, Chris has progressed to become a PMCF Manager. He leads on projects to assist a wide range of medical device manufacturers in the design, implementation, and analysis of PMCF surveys. Over the last 5 years Chris has gained experience in all aspects of the PMCF survey process and has worked with both high quality (level 4) and general usability surveys (level 8) over a range of device types and risk classifications.

Frank Matzek, DE

Former Vice President Regulatory & Governmental Affairs

BIOTRONIK SE & Co. KG

Frank Matzek served as the Vice President Regulatory & Governmental Affairs at BIOTRONIK in Berlin, Germany. BIOTRONIK is a leading global medical device com­pany with products and services that save and improve the lives of patients suffering from cardiovascular and endovascular diseases.

Frank holds a Dipl.-Ing. degree in biomedical engineering from the Technical Univer­sity of Berlin, is a certified quality engineer and has received a degree in business and administration from VWA Berlin.

In addition to his role with BIOTRONIK, Frank was actively involved in the industry associations MedTech Europe and BVMed Germany as a member/vice-chair of various core teams, work groups and committees.

Jacob Barkai, IL

Distinguished Product Security Architect

Edwards Lifesciences

Jacob Barkai is a Distinguished Product Security Architect at Edwards Lifesciences, with over two decades of experience in software engineering and cybersecurity.

Specializing in medical device security, Jacob leads technical initiatives at the intersection of AI, safety, and secure design.

Adam Gregory, DK

Head of Regulatory Affairs

Coloplast A/S

Adam Gregory currently leads the Regulatory Affairs team focused on Advanced Wound and Skin Care products in Coloplast A/S bringing positive change to patients where we work to make life easier for people living with wounds and the healthcare professionals who treat them. Adam has spent the last 8 years in Regulatory Affairs within the global medical device industry, with a specific focus on Rule 14 combination products from Advanced Wound Care and animal derived implantable devices and is keen to promote discourse on combination products to bring about positive industry changes.

Morten Cramer, DK

Head of HW/SW

InnoCon Medical

Software and hardware engineer and technical lead with 16 years of experience within medical device development. Worked on active implantable devices, combination products, and safety-critical software. Currently at InnoCon Medical, responsible for hardware and software and related processes.

InnoCon Medical have developed UCon, a partially implantable neuromodulation system, that relieves symptoms of incontinence. 

Harsh Jain, US

Senior Manager Quality Engineering

Align Technology

With over 15 years of experience in Product Quality Engineering for Medical Devices, Harsh Jain specializes in a broad array of technologies including Lab Analyzers, Arthroscopic Instruments, Tissue Ablation, Blood Management SaMD, Sequencing Technologies, Digital Health, Cardiac Wearables, and Orthodontic Devices.

He possesses extensive knowledge of the Medical Device Development Life Cycle (both software and hardware), Risk Management (including Product and Cybersecurity), and a strong understanding of US and International Regulatory Standards.

He is skilled at developing Quality Strategy Roadmaps for innovative and complex medical devices, ensuring that they meet compliance requirements, function reliably, and perform optimally in highly regulated environments. Education: MBA in Life Sciences, Master’s in Regulatory Affairs in Medical Devices, Master’s in Computer Science, Undergraduate degree in Mechanical Engineering.

Helena Neves, DK

Regulatory Affairs Specialist I SW

3Shape

Helena Neves is a Regulatory Affairs Specialist at 3Shape working with AI-enabled Software as Medical Device (SaMD). Responsible for supporting development teams across the full lifecycle of AI medical device development—from data governance and model validation to navigating global regulatory frameworks. Their recent work includes aligning AI development with the EU AI Act, MDR, and newest FDA Guidelines.

Dr. Hans-Martin von Stockhausen

Principal Key Expert for Cybersecurity

Siemens Healthineers

Dr. Saurabh Bhavsar, CH

Program Manager Digital Health

Ypsomed AG 

Dr. Fatima Sanfourche, DE

Global Sr. Director of QA & RA Compliance for Medical devices, Combination products, and eHealth

Bayer

Dr. Sepanta Fazaeli, NL

Clinical Systems & Medical Data Lead

Stryker

Alice Robertson, UK

PMCF Senior Executive

Purdie Pascoe

Chris Webb, UK

PMCF Manager

Purdie Pascoe

Frank Matzek, DE

Former Vice President Regulatory & Governmental Affairs

BIOTRONIK SE & Co. KG

Jacob Barkai, IL

Distinguished Product Security Architect

Edwards Lifesciences

Adam Gregory, DK

Head of Regulatory Affairs

Coloplast A/S

Morten Cramer, DK

Head of HW/SW

InnoCon Medical

Harsh Jain, US

Senior Manager Quality Engineering

Align Technology

Helena Neves, DK

Regulatory Affairs Specialist I SW

3Shape

BROCHURE

Request the 5th Medical Devices & SaMD: AI, Regulatory and Compliance Summit brochure and find out the latest topics and ideas that will be shared.

Request

Please fill in your e-mail address below, and we will process your request shortly.

Please note that some of our emails may be marked as spam due to your company’s security settings. To ensure we stay in touch, you can also connect directly with Emma at [email protected]

What our
participants
are saying

The summit provided exactly the kind of insight we needed to adapt to the evolving regulatory landscape. Sessions on the EU AI Act and MDR compliance were clear, practical, and highly relevant. It was great to connect with peers facing similar challenges.

1
2
3
4
5

Regulatory Affairs Expert

EU-based MedTech Company

From risk management workflows to AI transparency requirements, the summit delivered valuable, real-world content. I especially appreciated the discussions around IEC 62304 and ISO 14971 implementation—these are the challenges we live every day.

1
2
3
4
5

Software Architect

SaMD Product Development

A highly focused and expertly curated event. The mix of technical depth, regulatory updates, and strategic networking made it an essential stop for any company developing software-based medical technologies.

1
2
3
4
5

Head of Quality & Compliance

Digital Health Startup